Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Johnson and Johnson
Medtronic
Mallinckrodt
AstraZeneca
Daiichi Sankyo
Queensland Health
Chubb
Fish and Richardson

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,872,132

« Back to Dashboard

Summary for Patent: 5,872,132
Title: Form of paroxetine hydrochloride anhydrate
Abstract:"Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
Inventor(s): Ward; Neal (East Sussex, GB2), Jacewicz; Victor Witold (Kent, GB2)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:08/733,874
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 5,872,132

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,872,132

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9502297Feb 06, 1995
United Kingdom9503112Feb 17, 1995

International Patents Family Members for US Patent 5,872,132

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
France 2730232 ➤ Subscribe
Switzerland 688353 ➤ Subscribe
Germany 19603797 ➤ Subscribe
China 1216055 ➤ Subscribe
China 1310180 ➤ Subscribe
China 1090187 ➤ Subscribe
China 1143643 ➤ Subscribe
Switzerland 689229 ➤ Subscribe
Switzerland 689804 ➤ Subscribe
United Kingdom 9601917 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Julphar
US Army
Citi
McKesson
AstraZeneca
Federal Trade Commission
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot